MAPT and Alzheimer disease: There are two types of biomarkers: those that directly influence the pathology of AD, like the A beta-amyloid (Aβ) and tau proteins; and those that provide an indirect or non-specific indication of the disorder by locating indices of neuronal damage, which are considered to be the main cause of AD.